ENTERA BIO LTD. Payments of Stock Issuance Costs
ENTERA BIO LTD. (ENTX) reported Payments of Stock Issuance Costs of $171.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-07
- ENTERA BIO LTD. payments of stock issuance costs for the quarter ending 2026-06-30 was $171.00K, a 128.00% increase year-over-year.
- ENTERA BIO LTD. payments of stock issuance costs for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- ENTERA BIO LTD. payments of stock issuance costs for the quarter ending 2025-09-30 was $1.00K.
- ENTERA BIO LTD. payments of stock issuance costs for the quarter ending 2025-06-30 was $75.00K, a 294.74% increase year-over-year.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month |
|---|---|---|---|
| 2026-06-30 | $171.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $171.00K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-08 | ||
| 2025-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $76.00K derived: sum of 2 quarters · filed 2026-08-07 | $262.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $75.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $261.00K 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $186.00K 10-Q · filed 2026-05-08 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $19.00K derived: sum of 2 quarters · filed 2025-11-14 | $19.00K 10-Q · filed 2025-11-14 |
| 2024-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $19.00K 10-Q · filed 2025-08-08 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |